Applied Industrial Technologies (AIT) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
29 Nov, 2025Executive summary
Q3 2025 performance exceeded expectations for gross margin, EBITDA, EPS, and cash generation, despite a 3.1% organic sales decline and muted demand trends.
Net sales increased 1.8% year-over-year to $1.17 billion, driven by acquisitions, while organic sales declined and currency translation was unfavorable.
Margin expansion was supported by internal initiatives, cost controls, and the Hydradyne acquisition.
Free cash flow reached record levels, up 50% year-over-year in Q3 and 39% year-to-date, supporting over $440 million in capital deployment, including M&A and share buybacks.
Announced acquisition of IRIS Factory Automation and a new 1.5 million share repurchase authorization.
Financial highlights
Consolidated sales rose 1.8% year-over-year to $1.17 billion, with acquisitions contributing 6.6% growth; organic daily sales decreased 3.1%.
Gross margin expanded 95 bps to 30.5%; EBITDA margin increased 59 bps to 12.4%.
Reported EBITDA rose 6.8% year-over-year to $144.9 million; EPS was $2.57, up 3.7% from prior year.
Free cash flow for Q3 was $114.9 million (115% of net income), up 50% year-over-year; year-to-date free cash flow was $327 million, up 39%.
Net leverage ended at 0.4x EBITDA, with $353 million cash on hand.
Outlook and guidance
Fiscal 2025 EPS guidance updated to $9.85–$10.00, with sales growth flat to up 1% and organic sales down 4% to down 3%.
Q4 guidance: EPS $2.52–$2.67, sales down 1%–3% year-over-year, EBITDA margin 12.6%–12.8%.
April organic daily sales declined ~3% year-over-year; Q4 assumes mid to low single-digit organic sales decline.
Guidance reflects economic uncertainty, evolving tariffs, inflation, and cautious customer spending.
No contribution from future acquisitions or share buybacks included in guidance.
Latest events from Applied Industrial Technologies
- Sales up 8.4%, EPS up 4.6%–5.0%, guidance raised, and new acquisition plus higher dividend announced.AIT
Q2 20262 Feb 2026 - Record margins and strong cash flow offset soft demand; FY25 outlook remains cautious.AIT
Q4 20241 Feb 2026 - Net sales up 0.3%, EPS guidance raised, and free cash flow nearly doubled year-over-year.AIT
Q1 202518 Jan 2026 - Net income and EBITDA rose on margin gains; guidance and dividend increased after Hydradyne deal.AIT
Q2 20259 Jan 2026 - Record sales, strong governance, and pay-for-performance drive FY2025 proxy actions.AIT
Proxy Filing1 Dec 2025 - Board recommends electing three directors, approving pay, and ratifying Deloitte as auditor.AIT
Proxy Filing1 Dec 2025 - Record results and robust cash flow in 2025 set the stage for strong 2026 growth outlook.AIT
Q4 202523 Nov 2025 - Net sales up 9.2%, EPS and EBITDA rose double digits, FY26 EPS guidance increased.AIT
Q1 202629 Oct 2025